TARGETED RADIONUCLIDE THERAPY OF MELANOMA: ANTI-TUMOURAL EFFICACY OF A NEW IODINE-131 LABELLED AGENT

被引：0
|
作者：
Bonnet, M. [1 ]
Papon, J. [1 ]
Mishellany, F. [2 ]
Labarre, P. [1 ]
Maublant, J. [3 ]
Penault-Llorca, F. [2 ]
Cayre, A. [2 ]
Miot-Noirault, E. [1 ]
Madelmont, J. [1 ]
Chezal, J. [1 ]
Moins, N. [1 ]
机构：
[1] Univ Auvergne, CJP, EA4231, Clermont Ferrand, France
[2] Ctr Jean Perrin, Anat Pathol Lab, Clermont Ferrand, France
[3] Ctr Jean Perrin, Nucl Med Serv, Clermont Ferrand, France
来源：
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS | 2009年 / 52卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：S95 / S95
页数：1
相关论文
共 50 条
  • [1] Targeted radionuclide therapy of melanoma: Anti-tumoural efficacy studies of a new 131I labelled potential agent
    Bonnet-Duquennoy, Mathilde
    Papon, Janine
    Mishellany, Florence
    Labarre, Pierre
    Guerquin-Kern, Jean-Luc
    Wu, Ting-Di
    Gardette, Maryline
    Maublant, Jean
    Penault-Llorca, Frederique
    Miot-Noirault, Elisabeth
    Cayre, Anne
    Madelmont, Jean-Claude
    Chezal, Jean-Michel
    Moins, Nicole
    INTERNATIONAL JOURNAL OF CANCER, 2009, 125 (03) : 708 - 716
  • [2] Radionuclide therapy of melanoma: anti-tumor efficacy of a new vector labeled with iodine-131
    Bonnet-Duquennoy, Mathilde
    Janine, Papon
    Florence, Mishellany
    Jean-Luc, Guerquin-Kern
    Jean, Maublant
    Elisabeth, Miot-Noirault
    Anne, Cayre
    Jean-Claude, Madelmont
    Jean-Michel, Chezal
    Nicole, Moins
    BULLETIN DU CANCER, 2009, 96 : S8 - S8
  • [3] Targeted anti-tumoural therapy in the small animal practice
    Jakab Csaba
    MAGYAR ALLATORVOSOK LAPJA, 2014, 136 (04) : 230 - 230
  • [4] Iodine-131 labelled octreotide: Not an option for somatostatin receptor therapy
    Bakker, Willem H.
    Breeman, Wout A.P.
    Van Der Pluijm, Marcel E.
    De Jong, Marion
    Visser, Theo J.
    Krenning, Eric R.
    1996, Springer Verlag (23)
  • [5] Iodine-131 labelled octreotide: Not an option for somatostatin receptor therapy
    Bakker, WH
    Breeman, WAP
    vanderPluijm, ME
    deJong, M
    Visser, TJ
    Krenning, EP
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1996, 23 (07): : 775 - 781
  • [6] Direct Labeling of Gold Nanoparticles with Iodine-131 for Tumor Radionuclide Therapy
    Zhu, Meilin
    Zhao, Lingzhou
    Lu, Xia
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2024, 19 : 11805 - 11818
  • [7] [131I] ICF01012, a potential agent for targeted radionuclide therapy of melanoma
    Bonnet, M.
    Papon, J.
    Mishellany, F.
    Labarre, P.
    Maublant, J.
    Miot-Noirault, E.
    Cayre, A.
    Madelmont, J. C.
    Chezal, J. M.
    Moins, N.
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [8] Labeling of the Recombinant Streptokinase Using Iodine-131 as a New Thrombolytic Agent
    Daruwati, I.
    Hanafiah, A.
    Retnoningrum, D. S.
    Rachmawati, H.
    ATOM INDONESIA, 2012, 38 (03) : 106 - 111
  • [9] In vivo efficacy of melanoma internal radionuclide therapy with a 131I-labelled melanin-targeting heteroarylcarboxamide molecule
    Degoul, Francoise
    Borel, Michele
    Jacquemot, Nathalie
    Besse, Sophie
    Communal, Yves
    Mishellany, Florence
    Papon, Janine
    Penault-Llorca, Frederique
    Donnarieix, Denise
    Doly, Michel
    Maigne, Lydia
    Miot-Noirault, Elisabeth
    Cayre, Anne
    Cluzel, Jacques
    Moins, Nicole
    Chezal, Jean-Michel
    Bonnet, Mathilde
    INTERNATIONAL JOURNAL OF CANCER, 2013, 133 (05) : 1042 - 1053
  • [10] Nonmyeloablative iodine-131 anti-B1 radioimmunotherapy as outpatient therapy
    Gates, VL
    Carey, JE
    Siegel, JA
    Kaminski, MS
    Wahl, RL
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (07) : 1230 - 1236
12345